Emergent BioSolutions Repeatedly Cited by FDA

Jj Probs Vo 12 040100 00 04 26still001

The company at the center of the problems that led Johnson & Johnson to throw out 15 million doses of vaccines—has a list of citations from health officials

Emergent BioSolutions was a key to Johnson & Johnson’s plan to deliver 100 million doses of its vaccine to the U.S. by the end of May.

But records show Emergent has been repeatedly cited by the FDA for problems like poorly trained employees, cracked vials, and mold around one of its facilities.

Categories: Coronavirus